Dunhill Financial’s Guardant Health GH Stock Holding History

Dunhill Financial’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$234	Hold	1	–	–	﹤0.01%	1242
2026 Q1	$144	Sell	1 -1	-50%	-$100	﹤0.01%	1315
2025 Q4	$160	Buy	+2	New	+$179	﹤0.01%	1187

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Dunhill Financial's GH Position: Q2 2026 in Review

Dunhill Financial held its Guardant Health (GH) position steady in Q2 2026 at 1 share worth $234. The position accounts for ﹤0.01% of the portfolio, ranked #1242.

Dunhill Financial first reported a position in GH in Q4 2025 and has held it in 3 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Dunhill Financial held 1 share of Guardant Health worth $234 as of Q2 2026.
Dunhill Financial left its Guardant Health share count unchanged in Q2 2026.
Guardant Health made up ﹤0.01% of Dunhill Financial's portfolio in Q2 2026, its #1242 holding.
Dunhill Financial first reported a position in Guardant Health in Q4 2025 and has held it in 3 quarters since.
597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Dunhill Financial's 13F filing for Q2 2026, filed 7 Aug 2026.